Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:e59-e65
doi: 10.1161/hh0701.090462
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerfant, B. G.
Right arrow Articles by Gómez, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerfant, B. G.
Right arrow Articles by Gómez, A. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*COLCHICINE
Related Collections
Right arrow Structure
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Cell signalling/signal transduction
Right arrow Ion channels/membrane transport
(Circulation Research. 2001;88:e59.)
© 2001 American Heart Association, Inc.


Response to Research Commentary

Microtubule Disruption by Colchicine Reversibly Enhances Calcium Signaling in Intact Rat Cardiac Myocytes

B. G. Kerfant, G. Vassort, A. M. Gómez

From the Physiopathologie Cardiovasculaire, INSERM U-390, Montpellier, France.

Correspondence to Ana M. Gómez, INSERM U-390, CHU Arnaud de Villeneuve, 34295 Montpellier, France. E-mail agomez{at}montp.inserm.fr


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—Using the whole-cell patch-clamp configuration in rat ventricular myocytes, we recently reported that microtubule disruption increases calcium current (ICa) and [Ca2+]i transient and accelerates their kinetics by adenylyl cyclase activation. In the present report, we further analyzed the effects of microtubule disruption by 1 µmol/L colchicine on Ca2+ signaling in cardiac myocytes with intact sarcolemma. In quiescent intact cells, it is possible to investigate ryanodine receptor (RyR) activity by analyzing the characteristics of spontaneous Ca2+ sparks. Colchicine treatment decreased Ca2+ spark amplitude (F/F0: 1.78±0.01, n=983, versus 1.64±0.01, n=1660, recorded in control versus colchicine-treated cells; P<0.0001) without modifying the sarcoplasmic reticulum Ca2+ load and enhanced their time to peak (in ms: 6.85±0.09, n=1185, versus 7.33±0.13, n=1647; P<0.0001). Microtubule disruption also induced the appearance of Ca2+ sparks in doublets. These alterations may reflect RyR phosphorylation. To further investigate Ca2+ signaling in cardiac myocytes with intact sarcolemma, we analyzed [Ca2+]i transient evoked by field stimulation. Cells were loaded with the fluorescence Ca2+ indicator, Fluo-3 cell permeant, and stimulated at 1 Hz. [Ca2+]i transient amplitude was greater and its decay was accelerated in colchicine-treated, field-stimulated myocytes. This effect is reversible. When colchicine-treated myocytes were placed in a colchicine-free solution for 30 minutes, tubulin was repolymerized into microtubules, as shown by immunofluorescence, and the increase in [Ca2+]i transient was reversed. In summary, we demonstrate that microtubule disruption by colchicine reversibly modulates Ca2+ signaling in cardiac cells with intact sarcolemma. The full text of this article is available at http://www.circresaha.org.


Key Words: microtubules • calcium transient • calcium sparks • adenylyl cyclase


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Microtubules, components of the cytoskeleton, are involved in cell locomotion and mitosis. In adult cardiac cells, which do not undergo cell division, the role of microtubules has long been ignored, although interest began to focus on them after Tsutsui et al1 showed that microtubule content is increased in pressure-overload cardiac hypertrophy. Since the publication of that study, successive reports from the same team2 3 have reinforced the view that microtubule disruption increases contraction in failing myocytes. Following these observations, it was proposed that the increased microtubule network enhances the viscosity and/or rigidity of the failing myocyte.4 In contrast to the findings of Cooper and colleagues over the years, other investigators have not found an effect of colchicine treatment on contraction in either normal or failing hearts.5 6 7 The different experimental conditions and durations of colchicine exposure may account for these discrepancies. Even if one assumes that microtubule disruption will have more pronounced effects in cells with increased microtubule content, an effect, albeit smaller, should also be seen in normal myocytes. In fact, microtubule disruption has been shown to modulate beating rate and contraction,8 9 10 11 12 Ca2+ current,13 14 ß-adrenergic response,15 16 and [Ca2+]i transient amplitude17 in normal cells. Although the former studies on adult cells1 2 3 4 5 6 7 did not analyze [Ca2+]i transient, contraction measurements should follow [Ca2+]i transient unless microtubule disruption modifies myofilament Ca2+ sensitivity. To our knowledge, the only publications presenting an analysis of [Ca2+]i transient during microtubule alteration in adult cardiac myocytes are our recent report, in which an increase in [Ca2+]i transient after longer colchicine treatment was demonstrated,18 and one by Howarth et al,19 who showed a decrease in [Ca2+]i transient after microtubule stabilization with taxol, suggesting that microtubules may be important regulators of Ca2+ handling in the heart.

The Research Commentary from Calaghan et al20 analyzes the effects of colchicine treatment on contraction, [Ca2+]i transient, and ICa in adult rat cardiac myocytes in various experimental settings. Their results confirm our data obtained on myocytes under whole-cell or ruptured patch-clamp. However, under perforated patch-clamp, they found no effect of colchicine. Therefore, they suggested that membrane rupture under the patch pipette tip had influenced the colchicine effects.

In the present study, we demonstrate that colchicine treatment modulated Ca2+ signaling in freshly isolated intact cardiac myocytes: the characteristics of spontaneous Ca2+ sparks were altered in a way that is consistent with ryanodine receptor (RyR) phosphorylation. Moreover, the increase in the [Ca2+]i transient induced by microtubule disruption was reversible on colchicine washout.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Cell Preparation
Adult male Wistar rats (250 to 350 g) were anesthetized with sodium pentobarbital (100 mg/kg IP). Hearts were removed, and single ventricular myocytes were enzymatically (collagenase Worthington II, 1 mg/mL) isolated as previously described.21 Myocytes were stored in a Tyrode solution containing 1 mmol/L CaCl2 and maintained at room temperature. Some cells were supplemented with 1 µmol/L colchicine (dissolved in DMSO at 0.01% final DMSO concentration) at least 2 hours until used for experiments (2 to 6 hours). Experiments were performed on rod-shaped quiescent Ca2+-tolerant myocytes at room temperature (24°C to 25°C).

For experiments, myocytes were perfused with a Tyrode solution containing, in mmol/L: NaCl 140, MgCl2 0.5, KCl 5, glucose 5.5, HEPES 5, and CaCl2 1.8; pH was adjusted to 7.4 with NaOH.

Imaging of Ca2+ Sparks
Imaging was performed on Fluo-3–loaded myocytes using a laser scanning confocal microscope (Zeiss LSM 510), coupled to an inverted microscope (Axiovert 100M, Zeiss) and equipped with a x63 water immersion objective, 1.2 numerical aperture (C-Apochromat, Zeiss). Fluo-3 fluorescence was excited with the 488-nm line of an argon ion laser. Emitted fluorescence was measured at wavelengths over 515 nm. Image acquisition was made in the line-scan mode. A single myocyte was scanned repetitively along a line parallel to the longitudinal cell axis every 1.5 ms. Image processing and analysis of Ca2+ sparks were performed using IDL software (Research Systems), as previously described.22 Briefly, each image was background-subtracted. The fluorescence transient was obtained by averaging the fluorescence values in a 1.4-µm frame over time. Amplitude was measured as the maximum value of F/F0, where F is the fluorescence signal and F0 is the basal fluorescence (measured as the average of the 50 lowest values on the fluorescence transient). Decay time was calculated by fitting the descending phase of the fluorescence trace to a single exponential. Time to peak was measured in two ways: (1) absolute time to peak was measured as the time between the maximum of the second derivative and the peak F/F0 and (2) time to first peak was measured as the time between the maximum and minimum values of the second derivative. Half-width was measured from a transversal fluorescence transient obtained by averaging the fluorescence values in 15 ms over space and fitted to a Gauss function. These IDL routines allowed us to analyze a large number of Ca2+ sparks. When failure to converge occurred, the parameter was disregarded.

Field-Stimulation Experiments
Myocytes were loaded with the fluorescence membrane-permeant Ca2+ dye Fluo-3 AM, as previously described.21 Cells were placed on a Nikon microscope fitted with an epifluorescence attachment. Excitation was provided with a xenon lamp as previously described.18 The fluorescence signal was digitized (TL-1, Axon Instruments) and acquired at a sampling rate of 200 µs using pClamp 6. Cells were stimulated at a 1.5 excitation threshold through two platinum electrodes at 1 Hz. Data were acquired after 2 to 3 minutes of stabilization.

Immunolabeling
Single ventricular myocytes were permeabilized in a microtubule protective buffer, followed by 3% formaldehyde fixation.23 Antibodies were used as previously described.18 Confocal images were acquired with the Lasersharp program. Analysis was performed with IDL (Research Systems). 3D reconstruction of the Z-stack was achieved with Imaris (Bitplane).

Statistics
Data are presented as mean±SEM. An unpaired Student’s t test was performed to compare control and colchicine-treated cells, and a paired Student’s t test was used to compare drugs effects within each group. P<0.05 was considered significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Effects of Microtubule Disruption on Ca2+ Sparks
Cardiac excitation-contraction (EC) coupling is activated by the calcium-induced calcium release mechanism24 : membrane depolarization during each action potential activates sarcolemmal L-type calcium currents (ICa), leading to a local increase in [Ca2+]i around the neighboring sarcoplasmic reticulum (SR) Ca2+ release channels (RyRs). The activation of RyRs by Ca2+ triggers a large release of Ca2+ that activates cell contraction. The global [Ca2+]i transient is constituted by the spatial and temporal summation of its elementary units, Ca2+ sparks.25 Ca2+ sparks are localized Ca2+ transients that can be visualized in cardiac myocytes by using confocal imaging and appropriate Ca2+ dyes such as Fluo-3. They correspond to the synchronous activation of a cluster of RyRs. Consequently, in intact cells, RyR activity can be studied by analyzing Ca2+ spark properties.

Spontaneous Ca2+ sparks were analyzed in colchicine-treated myocytes and compared with those recorded in control myocytes. Figure 1Down shows averaged line-scan images corresponding to Ca2+ sparks recorded in a cell stored in the absence (Figure 1ADown) or presence (Figure 1BDown) of 1 µmol/L colchicine. To provide a better impression of average Ca2+ spark fluorescence intensity before and after colchicine treatment, each image is also represented by its 3D projection. It is clear that the fluorescence intensity decreased after microtubule disruption. Figure 1CDown shows the bar graph of the averaged Ca2+ spark amplitude. After colchicine treatment, Ca2+ spark amplitude was significantly smaller. The frequency histogram (Figure 1DDown) shows a shift toward Ca2+ sparks of lesser amplitudes. The decrease in Ca2+ spark amplitude could be due to a smaller SR Ca2+ load. We analyzed the SR Ca2+ load by rapid caffeine application.21 Figure 2ADown shows line-scan images of caffeine-induced Ca2+ release in a control (top) and a colchicine-treated cell (bottom). Averaged data (Figure 2BDown) show that microtubule disruption did not significantly modify SR Ca2+ content in quiescent cells, although there is a tendency to increase. Fluo-3 is a highly sensitive Ca2+ dye, and the fluorescence changes begin to be nonlinear at very high [Ca2+]. Therefore, it is possible that even if the fluorescence ratio increase did not reach statistical significance after colchicine treatment, there may be an increase in SR Ca2+ load, but in no case would there be a decrease. Thus, the decrease in Ca2+ spark amplitude was not due to a reduction in the SR Ca2+ content.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 1. Microtubule disruption decreases spontaneous Ca2+ spark amplitude. Signal-averaged line-scan images of 998 Ca2+ sparks recorded in 62 control myocytes (A) and 1660 Ca2+ sparks from 65 colchicine-treated myocytes (B). 3D projection of each image is shown in the bottom. The fluorescence signal (F) was normalized to the basal signal (F0). C, Bar graph showing Ca2+ spark amplitude in control (white bar, n=998) and colchicine-treated myocytes (blue bar, n=1660; *P<0.0001). D, Frequency histogram of the amplitude of spontaneous Ca2+ sparks. Microtubule disruption induces a shift toward smaller amplitudes.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 2. SR Ca2+ load is not significantly modified after microtubule disruption in quiescent myocytes. A, Line-scan images obtained during rapid application of 10 mmol/L caffeine in a control (top) and a colchicine-treated (bottom) myocyte. The color-coded scale bar indicates values of F/F0 ranging from 0 (black) to 5 (white). B, Bar graph corresponding to the caffeine-induced fluorescence [Ca2+]i transients in 29 control cells (white bar) and 20 colchicine-treated myocytes (blue bar).

The characteristics of Ca2+ sparks are given in the TableDown. In addition to Ca2+ spark amplitude, the only other parameter significantly altered by microtubule disruption was the time to peak, which was prolonged (Figure 3CDown). Further analysis of the lengthening in time to peak after colchicine treatment led us to observe [Ca2+]i peaks in doublets (Figures 3ADown and 3BDown). Then, when we analyzed the time to the first peak instead of the time to the absolute peak, no significant difference was found (TableDown). More than one peak (generally two) was observed in 9.6% of the Ca2+ sparks recorded after microtubule disruption. The frequency histograms corresponding to the distance and time between the first and second peaks are shown in Figure 3DDown. Most of the Ca2+ sparks in doublets occurred at the same spot or were very close to each other. The second peak rose {approx}15 to 20 ms after the first one. Thus, colchicine applied to intact quiescent cells significantly modulated Ca2+ spark characteristics, without altering the SR Ca2+ load.


View this table:
[in this window]
[in a new window]
 
Table 1. Effects of Cell Incubation With 1 µmol/L Colchicine on Ca2+ Spark Characteristics



View larger version (39K):
[in this window]
[in a new window]
 
Figure 3. Colchicine treatment induces Ca2+ sparks in doublets. Examples of a Ca2+ spark recorded in a control (A) and a colchicine-treated (B) myocyte. Below each image, the fluorescence trace (F/F0, measured as in Figure 1Up) obtained in the portion of the image indicated by the red line is shown. The color-coded scale is the same as in Figure 1Up. The image from the colchicine-treated myocyte presents 2 peaks. C, Bar graph showing the time to peak of the fluorescence signal in control (white bar, n=1185) and colchicine-treated cells (blue bar, n=1647); *P<0.0001. D, Frequency histograms indicating the distance (left) and the time (right) between 2 consecutive peaks, when present, in colchicine-treated myocytes.

Field-Stimulated [Ca2+]i Transients
We previously reported that microtubule disruption by colchicine increases global [Ca2+]i transient under whole-cell patch-clamp.18 This result has been challenged by Calaghan et al.20 They suggested that the increase in [Ca2+]i transient is related to the whole-cell patch-clamp technique, which implies the rupture of the membrane under the pipette tip. To further examine whether microtubule disruption could modulate Ca2+ signaling in intact myocytes, we analyzed [Ca2+]i transients in field-stimulated myocytes. Figure 4Down compares sample traces of fluorescence [Ca2+]i transients obtained in a control and a colchicine-treated myocyte. Isoproterenol application increased the [Ca2+]i transient in the control but was without effect on the colchicine-treated myocyte that originally demonstrated a larger [Ca2+]i transient. Pooled data are shown in Figure 4CDown. On average, [Ca2+]i transient amplitude increased 1.4-fold after microtubule disruption, whereas isoproterenol (1 µmol/L) significantly increased [Ca2+]i transient in control but not in colchicine-treated cells. These experiments were performed in a standard solution (see Materials and Methods) containing 1.8 mmol/L Ca2+. Although this is a Ca2+ concentration generally used to mimic physiological conditions, in some investigations 1 mmol/L Ca2+ is used. In this latter condition, the [Ca2+]i transient amplitude of 9 colchicine-treated cells was 1.34-fold that recorded in 10 control cells.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 4. Colchicine treatment increases [Ca2+]i transient in intact myocytes and prevents ß-adrenergic stimulation. Sample traces of [Ca2+]i transient (F, in arbitrary units, a.u.) obtained under field stimulation at 1 Hz in a control (A) and a colchicine-treated (B) ventricular cardiac myocyte in a solution containing 1.8 mmol/L CaCl2. Isoproterenol (ISO, 1 µmol/L) significantly increased [Ca2+]i transient in the control myocyte, but it had no effect on the colchicine-treated cell. The total duration of the experiment is shown on the x-axis. The time base of individual [Ca2+]i transients is indicated by the calibration bar. C, Bar graph showing averaged [Ca2+]i transient peaks in 9 control myocytes (white bar) before (open bar) and after (hatched bar) addition of 1 µmol/L ISO. Black bars represent values obtained in 7 colchicine-treated myocytes before (solid bar) and after (hatched bar) ISO application. The fluorescence signal (F) was normalized to the signal before stimulation (F0). D, Time-constant decay of the [Ca2+]i transient ({tau}) obtained by fitting the fluorescence trace to a single exponential. Bars are the same as in panel C for 7 control and 9 colchicine-treated myocytes bathed in a solution containing 1 mmol/L CaCl2. Colchicine treatment accelerates [Ca2+]i transient decay. ISO accelerates the decay only in control myocytes; *P<0.05, ** P<0.01.

The decay time ({tau}) of the [Ca2+]i transient was estimated by fitting to a first-order exponential function. Similarly to the decay of the ICa-evoked [Ca2+]i transient,18 the field-stimulated [Ca2+]i transient decay was accelerated in colchicine-treated cells (reduced to {approx}75%) (Figure 4DUp). This is consistent with the reduction to 80% reported by Calaghan et al20 at the same [Ca2+]o (see their TableUp). Sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA) is the main factor contributing to [Ca2+]i transient decay in rat cardiac myocytes.26 Its activity is enhanced after phospholamban phosphorylation by protein kinase A (PKA).26 The faster [Ca2+]i transient decay after colchicine treatment is in line with such a PKA activation. Furthermore, as is shown in Figure 4DUp, isoproterenol reduced the [Ca2+]i transient decay time in control cells, but it had no significant effect after microtubule disruption.

These results are consistent with our previous report on patch-clamped myocytes showing both an increase in [Ca2+]i transient and a loss of ß-adrenergic effect after colchicine treatment, as well as with the proposal that PKA is activated after Gs protein stimulation by free tubulin.18

Rescue of the Microtubule Network
It is often assumed that microtubule disruption by colchicine is poorly reversible; thus, most experiments are performed in control conditions on colchicine-treated cells. Figure 5ADown shows anti–ß-tubulin–labeled images of a control (top) and a colchicine-treated (middle) myocyte. Colchicine treatment markedly disrupted the microtubules, which was reflected by a decrease in fluorescence (Figure 5BDown). However, the immunolabeling of cells that were similarly treated by colchicine and then allowed a 30-minute washout demonstrated polymerized microtubules (Figure 5ADown, bottom), which was reflected by an increase in fluorescence (Figure 5BDown).



View larger version (65K):
[in this window]
[in a new window]
 
Figure 5. Effects of colchicine on the microtubule network and [Ca2+]i transient are reversible on washout. A, 3D reconstruction of confocal images taken along the z-axis after immunolabeling with anti–ß-tubulin in rat cardiomyocytes maintained in control solution (top), after 3-hour incubation with 1 µmol/L colchicine (middle), and after 30-minute colchicine washout (bottom). B, Bar graph showing averaged immunofluorescence in control (white bar, n=15) and colchicine-treated cells before (black bar, n=5) and after (hatched bar, n=24) 30-minute washout. C, Top, Examples of [Ca2+]i transients in a colchicine-treated myocyte elicited by field stimulation at 1 Hz before (a1) and after (a2) 30-minute colchicine washout. b1 and b2 show the same experimental protocol as in a1 and a2 except the cell was continuously perfused by a colchicine-containing solution. Bottom, Bar graph showing averaged amplitude of fluorescence [Ca2+]i transient (F/F0, measured as in Figure 4Up) at the end of the 30-minute period ([F/F0]end) normalized to the [Ca2+]i transient amplitude recorded in the same cell before the 30-minute period ([F/F0]start). During the 30-minute waiting period, the cell was perfused by a colchicine-free (hatched bar, n=5) or colchicine-containing (1 µmol/L, black bar, n=4) solution. All data were obtained in a bathing solution containing 1.8 mmol/L Ca2+ and no colchicine. *P<0.05 compared with the same cells at the beginning of the experiments.

Microtubule repolymerization after colchicine removal may have functional consequences. This is illustrated by the comparison of [Ca2+]i transients evoked by field stimulation on a colchicine-treated cell at the beginning of the experiment (Figure 5CUp, a1) and after a 30-minute colchicine washout (Figure 5CUp, a2). After this delay, [Ca2+]i transients had diminished toward control values. However, when colchicine was present throughout the experiment, the fluorescence [Ca2+]i transient remained about constant over the 30-minute period (Figure 5CUp, b). Average variations are presented in Figure 5CUp, bottom.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
Microtubules, which are components of the cytoskeleton, have a structural role and are generally acknowledged to be important to cell locomotion and mitosis. In adult cardiac myocytes, their role has been neglected because of their relatively low abundance. Tubulin concentration in these cells represents {approx}0.01% of total myocyte protein.27 28 However, a role as a second messenger could be important, because free tubulin has been shown to bind and activate G proteins.29 30 31 32 33 In general, the biological function of microtubules is based on the ability of tubulin to polymerize and depolymerize. Proper control of microtubule dynamics is essential for many microtubule-dependent processes. The present work extends our previous data.18 In the present study, we demonstrate that microtubule disruption modulates Ca2+ signaling in intact rat ventricular myocytes. Microtubule depolymerization by colchicine modulates spontaneous Ca2+ spark characteristics in quiescent cells and increases [Ca2+]i transient in field-stimulated cells. Furthermore, we show that the colchicine effects are partially reversible.

We previously reported that adenylyl cyclase (AC) is involved in the colchicine-induced alteration of Ca2+ signaling. The resulting PKA activation induces phosphorylation of the L-type Ca2+ channel. This would account for the increase in the whole-cell ICa and global [Ca2+]i transient.18 PKA has also been shown to phosphorylate RyRs,34 which dissociates them from FKBP12.635 and sorcin.36 Furthermore, dissociation of FKBP12.6 from RyR channels incorporated into planar bilayers results in subconductance states because of uncoupling of the RyRs that will not open synchronously.35 The decrease in Ca2+ spark amplitude found in cardiomyocytes after microtubule disruption may well reflect these alterations. Moreover, assuming the Ca2+ spark amplitude is decreased because fewer RyR channels open simultaneously to produce one spark, the increase in [Ca2+]i around the quiescent subset of RyRs on the same cluster may activate them, producing a second increase in [Ca2+]i. This possibility may underlie the increase in time to peak after microtubule disruption presented in Figure 3CUp. Another possibility is the reported acceleration of RyR adaptation after phosphorylation.34 The finding that after microtubule disruption many Ca2+ sparks are in doublets, together with the decrease in their peak amplitude, may indicate phosphorylation of the RyRs. This is consistent with our initial proposal that PKA is activated after microtubule disruption and is schematized in Figure 6Down.



View larger version (39K):
[in this window]
[in a new window]
 
Figure 6. Proposed mechanism of EC coupling modulation after microtubule disruption. Colchicine treatment induces an increase in the free {alpha}ß-tubulin that activates G protein and AC. PKA will be activated by the consequent elevation in cAMP and phosphorylate: Ca2+ channel (DHPR [dihydropyridine receptor]), increasing Ca2+ influx (ICa), and triggered Ca2+ release; phospholamban (PLN), accelerating Ca2+ uptake by SERCA; and RyRs, altering the characteristics of Ca2+ sparks.

At first glance, our results in field-stimulated myocytes (Figure 4Up) are inconsistent with the data presented by Calaghan et al.20 Our two sets of results differ in two aspects: the maintenance or nonmaintenance of the full ß-adrenergic response and the similarity or difference of the [Ca2+]i transient amplitude in control and colchicine-treated cells. As shown in their TableUp, Calaghan et al20 observed that colchicine, at 10 µmol/L, induced a significant acceleration of the [Ca2+]i transient decay in intact myocytes, as we did. Also, from the 30 cells presented in their TableUp, Calaghan et al studied the isoproterenol response in a subset of 9 cells. This subpopulation exhibited [Ca2+]i transient characteristics, such as the decay time constant, that were significantly different from those of the whole population (compare TableUp and Figure 3Up in Calaghan et al20 ). Their conclusion should thus be taken with caution. Furthermore, the bathing solution used by Calaghan et al contained insulin, which is known to increase ICa in rat cardiac myocytes.37 Insulin effects on rat ventricular myocytes are only seen in cells with an intact microtubule network.38 It is thus possible that [Ca2+]i transients were similar in control and colchicine-treated cells because ICa was increased by insulin only in the control myocytes, whereas it was increased by microtubule disruption in the colchicine-treated cells. An alternative explanation would be the low-stimulation frequency used by Calaghan et al,20 twice as slow as the stimulation frequency they used in another study on the decrease in [Ca2+]i transient after microtubule stabilization.19

Despite the difficulty, or impossibility, of accurately measuring ICa in rat ventricular myocytes without blocking K+ currents, Calaghan et al20 studied ICa under two variations of the same technique: conventional whole-cell patch-clamp and perforated patch-clamp. These investigators have obtained different results with these two techniques and suggested two major mechanisms to account for the different results: (1) the loss of cellular tubulin activates AC and (2) microtubule disruption renders cells more susceptible to mechanical stimulation.

The first suggestion is weakened by the following observations: (1) If free tubulin acts by binding and activating Gi protein in cardiac myocytes, after microtubule stabilization with taxol less tubulin will be free to activate Gi. Thus, no change or increase in [Ca2+]i transient would be expected after taxol application to intact cells. However, the opposite was demonstrated by Howarth et al.19 (2) Perforated patch-clamp was initially developed to reduce dialysis in small and spherical cells.39 Given the cardiac myocyte shape and the molecular weight of the complex {alpha}ß-tubulin–Gi protein, it is unlikely that free tubulin is rapidly lost. Indeed, we recorded an increased ICa in colchicine-treated ventricular myocytes even just after rupture of the patch (see Figure 7 in Reference 1818 ) that argues against the dialysis dependence of microtubule-disruption effects. (3) It is widely accepted that carbachol activates Gi protein and thus inactivates AC and decreases ICa, only if this pathway has been previously stimulated by PKA activation.40 After microtubule disruption, muscarinic stimulation effectively decreases ICa on whole-cell patch-clamped myocytes (Gallo MP, Malan D, Bendeti I, Biasin C, Alloatti G, Levi R, unpublished data, 2000) and isoproterenol recovers its activity (data not shown). This demonstrates both that the lack of isoproterenol effect is not due to intracellular dialysis and that Gi protein is not lost by dialysis. The Gs protein pathway is predominant in adult cardiac myocytes, whereas the Gi protein is predominant in neonatal myocytes.41 The entire set of data presented in this report and observed in intact cells argues against this hypothesis.

The finding by Calaghan et al20 that after 13 minutes of ruptured-patch achievement colchicine-treated myocytes are shrunk—compared with what occurs in control myocytes after 10 minutes—is surprising assuming no osmolarity differences between solutions and no negative pressure inside the pipette. Nevertheless, the suggestion that AC is activated as a result of mechanical stimulation, if any, in patch-clamp does not hold because the family of AC that is activated by cell deformation is not present in heart. Cardiac myocytes contain mainly type V and VI of AC, which are colocalized with the L-type Ca2+ channel42 and inhibited by low [Ca2+].43 44 45 46 The results presented in the present report were performed in myocytes with intact sarcolemma (neither ruptured nor perforated) and were consistent with the activation of AC after microtubule disruption we reported earlier. We observed that a 30-minute washout period in a colchicine-free solution allows for rescue of the microtubule network in colchicine-treated myocytes (Figure 5Up). Furthermore, together with tubulin repolymerization, [Ca2+]i transient elicited in field-stimulated myocytes is decreased. Other authors have also reported tubulin repolymerization on cardiac myocytes10 and isolated rat hearts.47

The discordance between the results of Calaghan et al20 obtained under two variations of the patch-clamp technique is unexpected. The strength of their argument is, however, weakened first by the technical difficulties related to the large series resistance in the perforated mode and, more importantly, by the maze of steps required to measure ICa in rat ventricular myocytes without effectively blocking K+ currents. Rat cardiocytes exhibit several outward K+ currents, including a large transient one (Ito), in a range of potentials overlapping with the one inducing activation of the inward ICa.48 49 Furthermore, the data of Calaghan et al in intact cells is not internally consistent (compare TableUp and Figures 3DUp and 2CUp in Calaghan et al20 under the same conditions). They do find an effect of colchicine in intact cells: an increase in [Ca2+]i (P<0.01) and an acceleration of [Ca2+]i transient decay (P<0.001). This last effect is characteristic of AC activation. Colchicine, in their hands, blocks some response to isoproterenol (their Figure 3CUp). The presence of insulin in their bathing solution and the selection of cells to analyze ß-adrenergic response (see previous discussion) may account for the apparent discrepancy with our results. In any case, they do observe some effects of colchicine on intact cardiomyocytes that would instead suggest that the perforated patch introduces some pitfalls, leading to a masking of colchicine effects.

Taken together, the present results demonstrate that microtubule disruption by colchicine does modulate Ca2+ handling in intact ventricular myocytes. Both Ca2+ spark characteristics in quiescent myocytes and Ca2+ transients in field-stimulated cardiomyocytes are altered by microtubule disruption. Microtubules in heart may thus have important implications in physiological and pathological conditions in which the level of tubulin polymerization is altered.


*    Acknowledgments
 
The Zeiss confocal microscope was bought thanks to financial support from INSERM and IFR3 (Institut National de la Santé et la Recherche Médicale, Institut Fédératif de Recherche No. 3), an HMR (Hoechst-Marion-Roussel) research grant, the AFM (Association Francaise contre les Myopathies), and the Région Languedoc-Roussillon. B.G.K. is a fellow from GRRC (Groupe de Réflexion sur la Recherche Cardiovasculaire), and A.M.G holds a CNRS (Centre National de la Recherche Scientifique) researcher position. We are indebted to Dr J.-L. Samuel for advice on ß-tubulin immunolabeling and Dr E. Scarfone for help with confocal imaging. We also thank Dr J.-P. Bénitah, Dr C. Delgado, and M.P. Heredia for helpful comments.


*    Footnotes
 
Original received December 18, 2000; revision received March 22, 2001; accepted March 22, 2001.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Tsutsui H, Ishihara K, Cooper G IV. Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science. 1993;260:682–687.[Abstract/Free Full Text]

2. Tagawa H, Koide M, Sato H, Zile MR, Carabello BA, Cooper G IV. Cytoskeletal role in the transition from compensated to decompensated hypertrophy during adult canine left ventricular pressure overloading. Circ Res. 1998;82:751–761.[Abstract/Free Full Text]

3. Ishibashi Y, Tsutsui H, Yamamoto S, Takahashi M, Imanaka-Yoshida K, Yoshida T, Urabe Y, Sugimachi M, Takeshita A. Role of microtubules in myocyte contractile dysfunction during cardiac hypertrophy in the rat. Am J Physiol. 1996;271:H1978–H1987.[Abstract/Free Full Text]

4. Tagawa H, Wang N, Narishige T, Ingber DE, Zile MR, Cooper G IV. Cytoskeletal mechanics in pressure-overload cardiac hypertrophy. Circ Res. 1997;80:281–289.[Abstract/Free Full Text]

5. Cicogna AC, Robinson KG, Conrad CH, Singh K, Squire R, Okoshi MP, Bing OH. Direct effects of colchicine on myocardial function: studies in hypertrophied and failing spontaneously hypertensive rats. Hypertension. 1999;33:60–65.[Abstract/Free Full Text]

6. Bailey BA, Dipla K, Li S, Houser SR. Cellular basis of contractile derangements of hypertrophied feline ventricular myocytes. J Mol Cell Cardiol. 1997;29:1823–1835.[Medline] [Order article via Infotrieve]

7. Collins JF, Pawloski-Dahm C, Davis MG, Ball N, Dorn GW II, Walsh RA. The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure. J Mol Cell Cardiol. 1996;28:1435–1443.[Medline] [Order article via Infotrieve]

8. Lampidis TJ, Kolonias D, Savaraj N, Rubin RW. Cardiostimulatory and antiarrhythmic activity of tubulin-binding agents. Proc Natl Acad Sci U S A. 1992;89:1256–1260.[Abstract/Free Full Text]

9. Lampidis TJ, Trevorrow KW, Rubin RW. Effects of colchicine on cardiac cell function indicate possible role for membrane surface tubulin. Exp Cell Res. 1986;164:463–470.[Medline] [Order article via Infotrieve]

10. Webster DR, Patrick DL. Beating rate of isolated neonatal cardiomyocytes is regulated by the stable microtubule subset. Am J Physiol. 2000;278:H1653–H1661.[Abstract/Free Full Text]

11. Kolodney MS, Elson EL. Contraction due to microtubule disruption is associated with increased phosphorylation of myosin regulatory light chain. Proc Natl Acad Sci U S A. 1995;92:10252–10256.[Abstract/Free Full Text]

12. Paul RJ, Bowman PS, Kolodney MS. Effects of microtubule disruption on force, velocity, stiffness and [Ca2+]i in porcine coronary arteries. Am J Physiol. 2000;279:H2493–H2501.[Abstract/Free Full Text]

13. Galli A, DeFelice LJ. Inactivation of L-type Ca channels in embryonic chick ventricle cells: dependence on the cytoskeletal agents colchicine and taxol. Biophys J. 1994;67:2296–2304.[Medline] [Order article via Infotrieve]

14. Unno T, Komori S, Ohashi H. Microtubule cytoskeleton involvement in muscarinic suppression of voltage-gated calcium channel current in guinea-pig ileal smooth muscle. Br J Pharmacol. 1999;127:1703–1711.[Medline] [Order article via Infotrieve]

15. Palmer BM, Valent S, Holder EL, Weinberger HD, Bies RD. Microtubules modulate cardiomyocyte ß-adrenergic response in cardiac hypertrophy. Am J Physiol. 1998;275:H1707–H1716.[Abstract/Free Full Text]

16. Limas C, Limas CJ. Disparate effects of colchicine on thyroxine-induced cardiac hypertrophy and adrenoceptor changes. Circ Res. 1991;68:309–313.[Abstract/Free Full Text]

17. Chevalier P, Kuznetsov V, Robinson RB, Rosen MR. Tubulin binding agent CI-980 has positive inotropic and local anesthetic actions. J Cardiovasc Pharmacol. 1994;23:944–951.[Medline] [Order article via Infotrieve]

18. Gomez AM, Kerfant BG, Vassort G. Microtubule disruption modulates Ca2+ signaling in rat cardiac myocytes. Circ Res. 2000;86:30–36.[Abstract/Free Full Text]

19. Howarth FC, Calaghan SC, Boyett MR, White E. Effect of the microtubule polymerizing agent taxol on contraction, Ca2+ transient and L-type Ca2+ current in rat ventricular myocytes. J Physiol. 1999;516:409–419.[Abstract/Free Full Text]

20. Calaghan SC, Le Guennec JY, White E. Modulation of Ca2+ signaling by microtubule disruption in rat ventricular myocytes and its dependence on the ruptured patch-clamp configuration. Circ Res. 2001;88:e32–e37.

21. Gomez AM, Cheng H, Lederer WJ, Bers DM. Ca2+ diffusion and sarcoplasmic reticulum transport both contribute to [Ca2+]i decline during Ca2+ sparks in rat ventricular myocytes. J Physiol. 1996;496:575–581.[Abstract/Free Full Text]

22. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 1997;276:800–806.[Abstract/Free Full Text]

23. Rappaport L, Samuel JL. Microtubules in cardiac myocytes. Int Rev Cytol. 1988;113:101–143.[Medline] [Order article via Infotrieve]

24. Fabiato A. Simulated calcium current can both cause calcium loading in and trigger calcium release from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J Gen Physiol. 1985;85:291–320.[Abstract/Free Full Text]

25. Cheng H, Lederer WJ, Cannell MB. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science. 1993;262:740–744.[Abstract/Free Full Text]

26. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, the Netherlands: Kluwer Academic Publishers; 1991.

27. Limas CJ. Myocardial colchicine-binding proteins: possible relation to DNA synthesis initiation. J Mol Cell Cardiol. 1979;11:1137–1150.[Medline] [Order article via Infotrieve]

28. Samuel JL, Schwartz K, Lompre AM, Delcayre C, Marotte F, Swynghedauw B, Rappaport L. Immunological quantitation and localization of tubulin in adult rat heart isolated myocytes. Eur J Cell Biol. 1983;31:99–106.[Medline] [Order article via Infotrieve]

29. Roychowdhury S, Wang N, Rasenick MM. G protein binding and G protein activation by nucleotide transfer involve distinct domains on tubulin: regulation of signal transduction by cytoskeletal elements. Biochemistry. 1993;32:4955–4961.[Medline] [Order article via Infotrieve]

30. Hatta S, Ozawa H, Saito T, Amemiya N, Ohshika H. Tubulin stimulates adenylyl cyclase activity in rat striatal membranes via transfer of guanine nucleotide to Gs protein. Brain Res. 1995;704:23–30.[Medline] [Order article via Infotrieve]

31. Wang N, Yan K, Rasenick MM. Tubulin binds specifically to the signal-transducing proteins, Gs{alpha} and Gi{alpha}1. J Biol Chem. 1990;265:1239–1242.[Abstract/Free Full Text]

32. Rasenick MM, Wang N, Yan K. Specific associations between tubulin and G proteins: participation of cytoskeletal elements in cellular signal transduction. Adv Second Messenger Phosphoprotein Res. 1990;24:381–386.[Medline] [Order article via Infotrieve]

33. Popova JS, Garrison JC, Rhee SG, Rasenick MM. Tubulin, Gq, and phosphatidylinositol 4,5-bisphosphate interact to regulate phospholipase Cß1 signaling. J Biol Chem. 1997;272:6760–6765.[Abstract/Free Full Text]

34. Valdivia HH, Kaplan JH, Ellis-Davies GC, Lederer WJ. Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation. Science. 1995;267:1997–2000.[Abstract/Free Full Text]

35. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365–376.[Medline] [Order article via Infotrieve]

36. Lokuta AJ, Meyers MB, Sander PR, Fishman GI, Valdivia HH. Modulation of cardiac ryanodine receptors by sorcin. J Biol Chem. 1997;272:25333–25338.[Abstract/Free Full Text]

37. Aulbach F, Simm A, Maier S, Langenfeld H, Walter U, Kersting U, Kirstein M. Insulin stimulates the L-type Ca2+ current in rat cardiac myocytes. Cardiovasc Res. 1999;42:113–120.[Abstract/Free Full Text]

38. Shimoni Y, Ewart HS, Severson D. Insulin stimulation of rat ventricular K+ currents depends on the integrity of the cytoskeleton. J Physiol. 1999;514:735–745.[Abstract/Free Full Text]

39. Pusch M, Neher E. Rates of diffusional exchange between small cells and a measuring patch pipette. Pflugers Arch. 1988;411:204–211.[Medline] [Order article via Infotrieve]

40. Fischmeister R, Hartzell HC. Mechanism of action of acetylcholine on calcium current in single cells from frog ventricle. J Physiol. 1986;376:183–202.[Abstract/Free Full Text]

41. Kumar R, Joyner RW, Hartzell HC, Ellingsen D, Rishi F, Eaton DC, Lu C, Akita T. Postnatal changes in the G-proteins, cyclic nucleotides and adenylyl cyclase activity in rabbit heart cells. J Mol Cell Cardiol. 1994;26:1537–1550.[Medline] [Order article via Infotrieve]

42. Gao T, Puri TS, Gerhardstein BL, Chien AJ, Green RD, Hosey MM. Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes. J Biol Chem. 1997;272:19401–19407.[Abstract/Free Full Text]

43. Hurley JH. Structure, mechanism, and regulation of mammalian adenylyl cyclase. J Biol Chem. 1999;274:7599–7602.[Free Full Text]

44. Pappano AJ, Shen JB. Carbachol inhibits L-type calcium current in BAPTA-dialyzed ventricular myocytes. Biophys J. 2000;78:100A. Abstract.

45. Gu C, Cooper DM. Ca2+, Sr2+, and Ba2+ identify distinct regulatory sites on adenylyl cyclase (AC) types VI and VIII and consolidate the apposition of capacitative cation entry channels and Ca2+-sensitive ACs. J Biol Chem. 2000;275:6980–6986.[Abstract/Free Full Text]

46. Yu HJ, Ma H, Green RD. Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes. Mol Pharmacol. 1993;44:689–693.[Abstract]

47. Tenpaku H, Onoda K, Imanaka-Yoshida K, Yoshida T, Shimono T, Shimpo H, Yada I. Terminal warm blood cardioplegia improves cardiac function through microtubule repolymerization. Ann Thorac Surg. 1998;65:1580–1587.[Abstract/Free Full Text]

48. Benitah JP, Gomez AM, Bailly P, Da Ponte JP, Berson G, Delgado C, Lorente P. Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts. J Physiol. 1993;469:111–138.[Abstract/Free Full Text]

49. Wickenden AD, Jegla TJ, Kaprielian R, Backx PH. Regional contributions of Kv1.4, Kv4.2, and Kv4.3 to transient outward K+ current in rat ventricle. Am J Physiol. 1999;276:H1599–H1607. [Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Y. Nakamura, T. Miura, A. Nakano, Y. Ichikawa, T. Yano, H. Kobayashi, Y. Ikeda, T. Miki, and K. Shimamoto
Role of microtubules in ischemic preconditioning against myocardial infarction
Cardiovasc Res, November 1, 2004; 64(2): 322 - 330.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. M. Gomez, I. Schuster, J. Fauconnier, J. Prestle, G. Hasenfuss, and S. Richard
FKBP12.6 overexpression decreases Ca2+ spark amplitude but enhances [Ca2+]i transient in rat cardiac myocytes
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1987 - H1993.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. M. Gomez, B.-G. Kerfant, G. Vassort, and A. J. Pappano
Autonomic regulation of calcium and potassium channels is oppositely modulated by microtubules in cardiac myocytes
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2065 - H2071.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerfant, B. G.
Right arrow Articles by Gómez, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerfant, B. G.
Right arrow Articles by Gómez, A. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*COLCHICINE
Related Collections
Right arrow Structure
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Cell signalling/signal transduction
Right arrow Ion channels/membrane transport